GOODRX HOLDINGS INC-CLASS A (GDRX) Stock Fundamental Analysis
USA - NASDAQ:GDRX - US38246G1085 - Common Stock
4.08 USD
-0.11 (-2.63%)
4.08 USD
0 (0%)
Taking everything into account, GDRX scores 6 out of 10 in our fundamental rating. GDRX was compared to 35 industry peers in the Health Care Technology industry. Both the profitability and the financial health of GDRX get a neutral evaluation. Nothing too spectacular is happening here. GDRX scores decently on growth, while it is valued quite cheap. This could make an interesting combination. This makes GDRX very considerable for value investing!
1. Profitability
1.1 Basic Checks
GDRX had positive earnings in the past year.
In the past year GDRX had a positive cash flow from operations.
GDRX had negative earnings in 4 of the past 5 years.
Each year in the past 5 years GDRX had a positive operating cash flow.
1.2 Ratios
GDRX's Return On Assets of 2.62% is amongst the best of the industry. GDRX outperforms 91.43% of its industry peers.
GDRX has a Return On Equity of 5.38%. This is amongst the best in the industry. GDRX outperforms 91.43% of its industry peers.
The Return On Invested Capital of GDRX (5.90%) is better than 88.57% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.62% | ||
| ROE | 5.38% | ||
| ROIC | 5.9% |
ROA(3y)-0.47%
ROA(5y)-4.59%
ROE(3y)-0.98%
ROE(5y)-9.45%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 4.33%, GDRX belongs to the top of the industry, outperforming 88.57% of the companies in the same industry.
GDRX's Profit Margin has declined in the last couple of years.
The Operating Margin of GDRX (11.10%) is better than 91.43% of its industry peers.
In the last couple of years the Operating Margin of GDRX has declined.
GDRX's Gross Margin of 93.68% is amongst the best of the industry. GDRX outperforms 100.00% of its industry peers.
In the last couple of years the Gross Margin of GDRX has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 11.1% | ||
| PM (TTM) | 4.33% | ||
| GM | 93.68% |
OM growth 3Y66.59%
OM growth 5Y-25.41%
PM growth 3YN/A
PM growth 5Y-34.38%
GM growth 3Y0.06%
GM growth 5Y-0.52%
2. Health
2.1 Basic Checks
GDRX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, GDRX has less shares outstanding
Compared to 5 years ago, GDRX has about the same amount of shares outstanding.
Compared to 1 year ago, GDRX has an improved debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of 0.96, we must say that GDRX is in the distress zone and has some risk of bankruptcy.
GDRX has a Altman-Z score (0.96) which is in line with its industry peers.
GDRX has a debt to FCF ratio of 4.14. This is a neutral value as GDRX would need 4.14 years to pay back of all of its debts.
GDRX has a Debt to FCF ratio (4.14) which is comparable to the rest of the industry.
A Debt/Equity ratio of 0.75 indicates that GDRX is somewhat dependend on debt financing.
GDRX's Debt to Equity ratio of 0.75 is on the low side compared to the rest of the industry. GDRX is outperformed by 77.14% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.75 | ||
| Debt/FCF | 4.14 | ||
| Altman-Z | 0.96 |
ROIC/WACC0.58
WACC10.16%
2.3 Liquidity
GDRX has a Current Ratio of 4.21. This indicates that GDRX is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 4.21, GDRX belongs to the top of the industry, outperforming 85.71% of the companies in the same industry.
A Quick Ratio of 4.21 indicates that GDRX has no problem at all paying its short term obligations.
GDRX has a Quick ratio of 4.21. This is amongst the best in the industry. GDRX outperforms 85.71% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.21 | ||
| Quick Ratio | 4.21 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 16.67% over the past year.
The earnings per share for GDRX have been decreasing by -24.47% on average. This is quite bad
The Revenue has been growing slightly by 3.19% in the past year.
Measured over the past years, GDRX shows a quite strong growth in Revenue. The Revenue has been growing by 15.34% on average per year.
EPS 1Y (TTM)16.67%
EPS 3Y0%
EPS 5Y-24.47%
EPS Q2Q%12.5%
Revenue 1Y (TTM)3.19%
Revenue growth 3Y2.06%
Revenue growth 5Y15.34%
Sales Q2Q%1.23%
3.2 Future
The Earnings Per Share is expected to grow by 24.30% on average over the next years. This is a very strong growth
Based on estimates for the next years, GDRX will show a small growth in Revenue. The Revenue will grow by 5.48% on average per year.
EPS Next Y15.74%
EPS Next 2Y18.32%
EPS Next 3Y16.99%
EPS Next 5Y24.3%
Revenue Next Year0.65%
Revenue Next 2Y2.95%
Revenue Next 3Y4.51%
Revenue Next 5Y5.48%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 11.66, which indicates a very decent valuation of GDRX.
Based on the Price/Earnings ratio, GDRX is valued cheaper than 100.00% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.27. GDRX is valued rather cheaply when compared to this.
The Price/Forward Earnings ratio is 8.83, which indicates a very decent valuation of GDRX.
Based on the Price/Forward Earnings ratio, GDRX is valued cheaply inside the industry as 97.14% of the companies are valued more expensively.
GDRX's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.77.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.66 | ||
| Fwd PE | 8.83 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, GDRX is valued cheaply inside the industry as 91.43% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, GDRX is valued cheaply inside the industry as 94.29% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 11.98 | ||
| EV/EBITDA | 9.8 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of GDRX may justify a higher PE ratio.
A more expensive valuation may be justified as GDRX's earnings are expected to grow with 16.99% in the coming years.
PEG (NY)0.74
PEG (5Y)N/A
EPS Next 2Y18.32%
EPS Next 3Y16.99%
5. Dividend
5.1 Amount
GDRX does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
4.08
-0.11 (-2.63%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners59.43%
Inst Owner Change-2.04%
Ins Owners11.7%
Ins Owner Change7.93%
Market Cap1.42B
Analysts75.45
Price Target5.43 (33.09%)
Short Float %8.15%
Short Ratio2.03
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-8.88%
Min EPS beat(2)-10.65%
Max EPS beat(2)-7.12%
EPS beat(4)0
Avg EPS beat(4)-8.86%
Min EPS beat(4)-10.65%
Max EPS beat(4)-7.12%
EPS beat(8)3
Avg EPS beat(8)-2.89%
EPS beat(12)7
Avg EPS beat(12)10.95%
EPS beat(16)10
Avg EPS beat(16)12.15%
Revenue beat(2)0
Avg Revenue beat(2)-2.45%
Min Revenue beat(2)-3.3%
Max Revenue beat(2)-1.6%
Revenue beat(4)0
Avg Revenue beat(4)-2.4%
Min Revenue beat(4)-3.3%
Max Revenue beat(4)-1.6%
Revenue beat(8)0
Avg Revenue beat(8)-2.55%
Revenue beat(12)1
Avg Revenue beat(12)-1.8%
Revenue beat(16)2
Avg Revenue beat(16)-1.63%
PT rev (1m)-15.79%
PT rev (3m)-16.23%
EPS NQ rev (1m)0.1%
EPS NQ rev (3m)-6.07%
EPS NY rev (1m)-3.45%
EPS NY rev (3m)-3.59%
Revenue NQ rev (1m)-0.47%
Revenue NQ rev (3m)-5.4%
Revenue NY rev (1m)-2.57%
Revenue NY rev (3m)-2.56%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.66 | ||
| Fwd PE | 8.83 | ||
| P/S | 1.77 | ||
| P/FCF | 11.98 | ||
| P/OCF | 7.43 | ||
| P/B | 2.2 | ||
| P/tB | 81.2 | ||
| EV/EBITDA | 9.8 |
EPS(TTM)0.35
EY8.58%
EPS(NY)0.46
Fwd EY11.32%
FCF(TTM)0.34
FCFY8.35%
OCF(TTM)0.55
OCFY13.47%
SpS2.3
BVpS1.85
TBVpS0.05
PEG (NY)0.74
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.62% | ||
| ROE | 5.38% | ||
| ROCE | 7.47% | ||
| ROIC | 5.9% | ||
| ROICexc | 7.74% | ||
| ROICexgc | 24.97% | ||
| OM | 11.1% | ||
| PM (TTM) | 4.33% | ||
| GM | 93.68% | ||
| FCFM | 14.8% |
ROA(3y)-0.47%
ROA(5y)-4.59%
ROE(3y)-0.98%
ROE(5y)-9.45%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y37.95%
ROICexcg growth 5Y-33.14%
ROICexc growth 3Y52.2%
ROICexc growth 5Y-28.33%
OM growth 3Y66.59%
OM growth 5Y-25.41%
PM growth 3YN/A
PM growth 5Y-34.38%
GM growth 3Y0.06%
GM growth 5Y-0.52%
F-Score8
Asset Turnover0.61
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.75 | ||
| Debt/FCF | 4.14 | ||
| Debt/EBITDA | 2.92 | ||
| Cap/Depr | 93.99% | ||
| Cap/Sales | 9.07% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 115.02% | ||
| Profit Quality | 342.04% | ||
| Current Ratio | 4.21 | ||
| Quick Ratio | 4.21 | ||
| Altman-Z | 0.96 |
F-Score8
WACC10.16%
ROIC/WACC0.58
Cap/Depr(3y)84.93%
Cap/Depr(5y)109.87%
Cap/Sales(3y)7.84%
Cap/Sales(5y)6.93%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.67%
EPS 3Y0%
EPS 5Y-24.47%
EPS Q2Q%12.5%
EPS Next Y15.74%
EPS Next 2Y18.32%
EPS Next 3Y16.99%
EPS Next 5Y24.3%
Revenue 1Y (TTM)3.19%
Revenue growth 3Y2.06%
Revenue growth 5Y15.34%
Sales Q2Q%1.23%
Revenue Next Year0.65%
Revenue Next 2Y2.95%
Revenue Next 3Y4.51%
Revenue Next 5Y5.48%
EBIT growth 1Y407.89%
EBIT growth 3Y70.01%
EBIT growth 5Y-13.97%
EBIT Next Year37.85%
EBIT Next 3Y17.74%
EBIT Next 5Y12.79%
FCF growth 1Y70.28%
FCF growth 3Y-7.68%
FCF growth 5Y7.91%
OCF growth 1Y49.36%
OCF growth 3Y0.94%
OCF growth 5Y17.16%